Published in Circulation on November 19, 2012
Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med (2015) 5.81
Ranolazine: A Contemporary Review. J Am Heart Assoc (2016) 3.67
Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation (2013) 1.89
Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation (2013) 1.87
Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations. JAMA (2014) 1.79
Evaluating the efficacy of an education and treatment program for patients with coronary heart disease. Dtsch Arztebl Int (2014) 1.73
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol (2015) 1.01
Omega-3 index and cardiovascular health. Nutrients (2014) 0.94
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading? J Cardiovasc Transl Res (2015) 0.92
Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med (2014) 0.87
Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept. Circulation (2014) 0.86
Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives. Adv Nutr (2015) 0.85
Total arterial grafting is associated with improved clinical outcomes compared to conventional myocardial revascularization at 10 years follow-up. Heart Vessels (2016) 0.85
Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg (2014) 0.83
Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease. Ann Thorac Surg (2013) 0.82
Cross-vendor evaluation of key user-defined clinical decision support capabilities: a scenario-based assessment of certified electronic health records with guidelines for future development. J Am Med Inform Assoc (2015) 0.82
Chronic total occlusion: To treat or not to treat. World J Cardiol (2014) 0.82
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review. Cardiovasc Ther (2016) 0.80
Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society. Diabetol Metab Syndr (2014) 0.79
Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol (2014) 0.79
Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study. Clin Res Cardiol (2014) 0.79
Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther (2015) 0.78
Prevention, Detection and Management of Coronary Artery Disease in Minority Females. Ethn Dis (2015) 0.78
Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression. Eur J Nucl Med Mol Imaging (2016) 0.78
Hemodynamic effect of avanafil and glyceryl trinitrate coadministration. Drugs Context (2013) 0.78
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes (2013) 0.78
Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies. Open Heart (2015) 0.77
Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease. Popul Health Manag (2014) 0.77
I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice. BMC Cardiovasc Disord (2014) 0.77
Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study. PLoS One (2016) 0.77
Diet and exercise interventions following coronary artery bypass graft surgery: a review and call to action. Phys Sportsmed (2014) 0.77
Management of Coronary Artery Calcium and Coronary CTA Findings. Curr Cardiovasc Imaging Rep (2015) 0.76
What do the recent American Heart Association/American College of Cardiology Foundation Clinical Practice Guidelines tell us about the evolving management of coronary heart disease in older adults? J Geriatr Cardiol (2013) 0.76
The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry. PLoS One (2015) 0.75
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction. Am Heart J (2015) 0.75
Cumulative stress and autonomic dysregulation in a community sample. Stress (2016) 0.75
Interleukin 17A in Patients With Stable Coronary Artery Disease: Are There Differences According to Gender? Cardiol Res (2014) 0.75
Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos (2014) 0.75
β-blockers for secondary prevention in stable coronary artery disease: can observational studies provide valid answers? Heart (2014) 0.75
Head to Head Comparison of Stress Echocardiography with Exercise Electrocardiography for the Detection of Coronary Artery Stenosis in Women. J Cardiovasc Ultrasound (2016) 0.75
Effects of cardiac medications for patients with obstructive coronary artery disease by coronary computed tomographic angiography: results from the multicenter CONFIRM registry. Atherosclerosis (2014) 0.75
Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease. Clin Imaging (2017) 0.75
Experimental and early investigational drugs for angina pectoris. Expert Opin Investig Drugs (2016) 0.75
Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. J Am Heart Assoc (2016) 0.75
Deciphering the genetic and modular connections between coronary heart disease, idiopathic pulmonary arterial hypertension and pulmonary heart disease. Mol Med Rep (2016) 0.75
Telemedicine-supported transition of stable coronary artery disease patients from tertiary to primary health care facilities: protocol for a randomized non-inferiority trial. BMC Health Serv Res (2016) 0.75
The neutrophil to lymphocyte ratio improves the positive predictive value of dobutamine stress echocardiography. Int J Clin Exp Med (2015) 0.75
Association Between Ankle-Brachial Index and Coronary Lesions Assessed by Coronary Angiography. Cardiol Res (2015) 0.75
Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention. Adv Ther (2015) 0.75
Impact of impaired fractional flow reserve after coronary interventions on outcomes: a systematic review and meta-analysis. BMC Cardiovasc Disord (2016) 0.75
Role of short-acting nitroglycerin in the management of ischemic heart disease. Drug Des Devel Ther (2015) 0.75
Correlation between C-reactive protein in peripheral vein and coronary sinus in stable and unstable angina. Arq Bras Cardiol (2014) 0.75
Cardiovascular risk in psoriatic arthritis - a cross-sectional study. Maedica (Buchar) (2014) 0.75
Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina. Drugs R D (2013) 0.75
Incidence and Predictors of Catheterization-Related Cerebral Infarction on Diffusion-Weighted Magnetic Resonance Imaging. Biomed Res Int (2016) 0.75
Evaluating symptoms to improve quality of life in patients with chronic stable angina. Nurs Res Pract (2013) 0.75
Yield of contemporary clinical strategies to detect patients with obstructive coronary artery disease. Heart Int (2016) 0.75
Risk stratification in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80. Prog Cardiovasc Dis (2014) 0.75
Effect of coronary artery bypass graft surgery on left ventricular systolic function. J Thorac Dis (2017) 0.75
The Role of Ivabradine in the Management of Angina Pectoris. Cardiovasc Drugs Ther (2016) 0.75
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization. Angiology (2016) 0.75
Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study. Ther Clin Risk Manag (2015) 0.75
Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery. Medicine (Baltimore) (2015) 0.75
Brain Arterial Diameters as a Risk Factor for Vascular Events. J Am Heart Assoc (2015) 0.75
The associations between serum biomarkers and stenosis of the coronary arteries. Oncotarget (2016) 0.75
Revascularization for silent ischemia?: another piece of the puzzle. J Am Coll Cardiol (2013) 0.75
Cost-effectiveness of anatomical and functional test strategies for stable chest pain: public health perspective from a middle-income country. BMJ Open (2017) 0.75
Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease. Yonsei Med J (2017) 0.75
Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice. Cardiol Ther (2017) 0.75
Discovery and Development of Calcium Channel Blockers. Front Pharmacol (2017) 0.75
Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study. BMJ Open (2017) 0.75
Analyzing cardiovascular treatment guidelines application to women and minority populations. SAGE Open Med (2017) 0.75
Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association. J Am Heart Assoc (2017) 0.75
The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease. J Geriatr Cardiol (2017) 0.75
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial. Trials (2017) 0.75
Noninvasive measurement of pressure gradient across a coronary stenosis using phase contrast (PC)-MRI: A feasibility study. Magn Reson Med (2016) 0.75
Screening for coronary artery disease in patients with type 2 diabetes: a meta-analysis and trial sequential analysis. BMJ Open (2017) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA (2003) 10.55
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Estimated radiation dose associated with cardiac CT angiography. JAMA (2009) 8.31
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA (2004) 7.32
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77